451 related articles for article (PubMed ID: 3582746)
21. Cell growth and monoclonal antibody production in the presence of antigen and serum.
Dandulakis G; Herr JC; Kirwan DJ
Biotechnol Prog; 1995; 11(5):518-24. PubMed ID: 8546836
[TBL] [Abstract][Full Text] [Related]
22. Increasing the culture efficiency of hybridoma cells by the use of integrated metabolic control of glucose and glutamine at low levels.
Li L; Mi L; Feng Q; Liu R; Tang H; Xie L; Yu X; Chen Z
Biotechnol Appl Biochem; 2005 Aug; 42(Pt 1):73-80. PubMed ID: 15748147
[TBL] [Abstract][Full Text] [Related]
23. Production of monoclonal antibody in hollow fiber culture system with serum-free medium.
Zhou W; Cai S
Chin J Biotechnol; 1992; 8(1):41-9. PubMed ID: 1457721
[TBL] [Abstract][Full Text] [Related]
24. Effects of dissolved oxygen on hybridoma cell growth, metabolism, and antibody production kinetics in continuous culture.
Ozturk SS; Palsson BO
Biotechnol Prog; 1990; 6(6):437-46. PubMed ID: 1366834
[TBL] [Abstract][Full Text] [Related]
25. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
Dong H; Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
[TBL] [Abstract][Full Text] [Related]
26. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
27. Fractional factorial study of hybridoma behavior. 1. Kinetics of growth and antibody production.
Gaertner JG; Dhurjati P
Biotechnol Prog; 1993; 9(3):298-308. PubMed ID: 7763699
[TBL] [Abstract][Full Text] [Related]
28. In pursuit of the optimal fed-batch process for monoclonal antibody production.
Bibila TA; Robinson DK
Biotechnol Prog; 1995; 11(1):1-13. PubMed ID: 7765983
[TBL] [Abstract][Full Text] [Related]
29. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
[TBL] [Abstract][Full Text] [Related]
30. Role of metabolic waste products in the control of cell proliferation and antibody production by mouse hybridoma cells.
Duval D; Demangel C; Miossec S; Geahel I
Hybridoma; 1992 Jun; 11(3):311-22. PubMed ID: 1500067
[TBL] [Abstract][Full Text] [Related]
31. Growth kinetics of hybridoma cells: (2) The effects of varying energy source concentrations.
Low K; Harbour C
Dev Biol Stand; 1985; 60():73-9. PubMed ID: 4043544
[TBL] [Abstract][Full Text] [Related]
32. Production of human monoclonal antibodies from immobilized cells in the Opticell culture system.
Bödeker BG; Hübner GE; Hewlett G; Schlumberger HD
Dev Biol Stand; 1987; 66():473-9. PubMed ID: 3582768
[TBL] [Abstract][Full Text] [Related]
33. Elucidation of metabolism in hybridoma cells grown in fed-batch culture by genome-scale modeling.
Selvarasu S; Wong VV; Karimi IA; Lee DY
Biotechnol Bioeng; 2009 Apr; 102(5):1494-504. PubMed ID: 19048615
[TBL] [Abstract][Full Text] [Related]
34. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process.
Yang JD; Angelillo Y; Chaudhry M; Goldenberg C; Goldenberg DM
Biotechnol Bioeng; 2000 Jul; 69(1):74-82. PubMed ID: 10820333
[TBL] [Abstract][Full Text] [Related]
35. Multi-stage high cell continuous fermentation for high productivity and titer.
Chang HN; Kim NJ; Kang J; Jeong CM; Choi JD; Fei Q; Kim BJ; Kwon S; Lee SY; Kim J
Bioprocess Biosyst Eng; 2011 May; 34(4):419-31. PubMed ID: 21127908
[TBL] [Abstract][Full Text] [Related]
36. Statistical methods in media optimization for batch and fed-batch animal cell culture.
De Alwis DM; Dutton RL; Scharer J; Moo-Young M
Bioprocess Biosyst Eng; 2007 Mar; 30(2):107-13. PubMed ID: 17242929
[TBL] [Abstract][Full Text] [Related]
37. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
[TBL] [Abstract][Full Text] [Related]
38. A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Wang IK; Hsieh SY; Chang KM; Wang YC; Chu A; Shaw SY; Ou JJ; Ho L
J Biotechnol; 2006 Feb; 121(3):418-28. PubMed ID: 16162365
[TBL] [Abstract][Full Text] [Related]
39. Increased t-PA yields using ultrafiltration of an inhibitory product from CHO fed-batch culture.
Dowd JE; Kwok KE; Piret JM
Biotechnol Prog; 2000; 16(5):786-94. PubMed ID: 11027171
[TBL] [Abstract][Full Text] [Related]
40. A new serum-free medium for monoclonal antibody production.
Wolfe RA; Braatz JA; Miller DA; Heifetz AH
Biotechniques; 1988 Jan; 6(1):62-7. PubMed ID: 3273394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
